Wegovy has been approved for use among the growing number of Americans who have MASH.

Semaglutide (Wegovy) is the first GLP-1 receptor agonist approved for MASH with liver fibrosis, excluding cirrhosis cases. The phase 3 ESSENCE trial demonstrated significant liver outcome ...

Michter’s Long-Awaited US*1 Toasted Barrel Finish Sour Mash Is Finally Back — Here’s What to Expect Sour Mash doesn’t fit bourbon or rye rules, and that’s its strength.

New York City could grant payouts to some 20,000 taxi drivers whose professional licenses were summarily suspended without sufficient due process.

The FDA has approved Wegovy for the treatment of adults with noncirrhotic metabolic dysfunction-associated steatohepatitis with moderate to advanced liver fibrosis.Semaglutide 2.4 mg injection ...

Novo Nordisk (NVO) stock in focus as the company wins FDA accelerated nod for weight loss therapy Wegovy against the liver disease MASH. Read more here.

Novo Nordisk’s obesity drug Wegovy was cleared by U.S. regulators to treat an increasingly common liver disease, MASH.

Novo Nordisk’s GLP-1 drug Wegovy expanded its label to include the metabolic disorder known as MASH. Analysts say there’s room for many MASH drugs with the treatment landscape expected to ...

With a new FDA nod, Novo's GLP-1 Wegovy has scored its third indication and become the second drug approved in a severe form of fatty liver disease.

Danny DeVito Says It Was “A Gift” Reuniting with ‘Taxi’ Co-Star Carol Kane in the ‘It’s Always Sunny In Philadelphia’ Season 17 Finale: “This Part Was Perfect for Her” ...

Novo Nordisk said on Friday the U.S. Food and Drug Administration has granted accelerated approval for its weight-loss drug Wegovy to treat a serious liver condition called metabolic dysfunction ...

Dubai’s culinary scene has changed with the arrival of the Michelin Guide and Middle East and North Africa’s 50 Best ...